Trial Profile
Randomized, comparative trial of DOX-SL (stealth liposomal doxorubicin hydrochloride) [doxorubicin liposomal] versus adriamycin [doxorubicin], bleomycin, and vincristine (ABV) in the treatment of severe AIDS-related Kaposi's sarcoma
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Bleomycin; Doxorubicin; Vincristine
- Indications Kaposi's sarcoma
- Focus Therapeutic Use
- 11 Sep 2005 New trial record.